The customer is a US-based pharmaceutical company looking for Regulatory support in filing ad hoc submissions to the UDFDA. Challenges in the form of strict timelines and taking care of end-to-end publishing activities were part of the project. Freyr’s dedicated team of experts was able to accomplish granular Document Level Publishing in a short period. By studying the documents and ensuring zero defects before filing the Annual Report and meeting requests, Freyr assisted the customer meet their business objectives.
How did Freyr make timely Annual Report and meeting requests submissions to the USFDA with zero defects? Download the proven case.
Fill the form below to download the Case Study
